Skip to main content
. 2013 Jan 29;15(5):535–541. doi: 10.1093/neuonc/nos324

Table 3.

Case-control ORs of IDH1/2–mutated gliomas with rs498872 T allele and rs55705857 G allele in UCSF Adult Glioma and Mayo Clinic Studies

Variable Number rs498872 (T allele)
rs55705857 (G allele)
RAF OR (95% CI) P value RAF OR (95% CI) P value
Controls 1300 0.32 0.05
IDH mutated tumors
 All gliomas 359 0.42 1.52 (1.27–1.83) 5.1E-06 0.19 5.21 (3.90–6.96) 6.8E-29
 Glioblastomas 48 0.46 1.84 (1.19–2.85) 6.2E-03 0.22 7.55 (4.12–13.9) 6.5E-11
 Gr 2 Gliomas 180 0.39 1.42 (1.12–1.80) 4.3E-03 0.21 5.56 (3.93–7.88) 4.5E-22
 Gr 3 Gliomas 131 0.44 1.60 (1.23–2.07) 4.4E-04 0.16 4.25 (2.83–6.38) 2.8E-12
 Oliodendrogliomas Gr 2/3 107 0.42 1.60 (1.18–2.16) 2.3E-03 0.20 5.89 (3.83–9.07) 7.6E-16
 Oliogoastrocytomas Gr 2/3 74 0.39 1.33 (0.95–1.88) 0.10 0.16 3.73 (2.30–6.04) 9.0E-08
 Astrocytomas Gr 2/3 130 0.42 1.54 (1.18–2.02) 1.7E-03 0.19 5.37 (3.59–8.04) 3.4E-16

Note: Fewer subjects had data available for rs55705857 than for rs498872 because only a recently completed custom genotyping panel22 contained rs55705857.

ORs for each glioma subtype are from an additive model that includes both 0, 1, or 2 T alleles in rs498872 and 0, 1, or 2 G alleles in rs55705857 and is adjusted for study site. P values ≤ .05 are in bold.

RAF = risk allele frequency.